Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02840747 · ClinicalTrials.gov registry record
Tissue Repository: CTCL Collection Protocol
A clinical trial of Sezary Syndrome and Lymphoma, T-Cell, Cutaneous, sponsored by Columbia University.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT02840747: Recruiting study of Sezary Syndrome and Lymphoma, T-Cell, Cutaneous, sponsored by Columbia University.
NCT02840747 is a study of Sezary Syndrome and Lymphoma, T-Cell, Cutaneous that is actively recruiting participants, run by Columbia University. The registered enrollment target is 400 participants, above the 52-participant average among 13 other Sezary Syndrome trials with a reported enrollment target (669% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02840747, a study of Sezary Syndrome and Lymphoma, T-Cell, Cutaneous, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This document is a protocol for a non-interventional human research study in which the investigator hopes to better understand the changes that take place in T cells in Cutaneous T-cell lymphoma (CTCL). The purpose of this study is to establish a protocol for the collection and storage of tissue samples from patients with CTCL for future research studies. Collection and storage of tissue samples from control patients will also be carried out.
Primary Outcome
This is a collection protocol to establish a tissue repository for samples from patients with CTCL.
Conditions Studied
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2016-07 |
| Est. Completion | 2026-10 |
What NCT02840747 shows while recruiting
NCT02840747 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 52-participant average among 13 other Sezary Syndrome trials with a reported enrollment target (669% higher).
The record links to 3 conditions, with Sezary Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT02840747 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02840747 about?
NCT02840747 is a clinical study titled "Tissue Repository: CTCL Collection Protocol". This document is a protocol for a non-interventional human research study in which the investigator hopes to better understand the changes that take place in T cells in Cutaneous T-cell lymphoma (CTCL). The purpose of this study is to establish a protocol for the collection and storage of tissue sam...
What is the current status of trial NCT02840747?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2016-07. Estimated completion is 2026-10.
What conditions does trial NCT02840747 study?
This clinical trial studies the following conditions: Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphomatoid Papulosis.
Who is sponsoring clinical trial NCT02840747?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02840747 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sezary Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02840747's enrollment target sits among peer trials
400 1st of 13 higher than 13 of 13 other Sezary Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sezary Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
RECRUITING
-
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
RECRUITING · Phase 2
-
Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
RECRUITING · Phase 2
-
Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
RECRUITING · Phase 2
-
Extracorporeal Photopheresis in Sezary Syndrome
RECRUITING
-
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia